APA (7th ed.) Citation

Broghammer, F., Korovina, I., Gouda, M., Celotti, M., van Es, J., Lange, I., . . . Cordes, N. (2024). Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome. Molecular Cancer, 23(1), 1. https://doi.org/10.1186/s12943-024-01954-8

Chicago Style (17th ed.) Citation

Broghammer, Felix, et al. "Resistance of HNSCC Cell Models to Pan-FGFR Inhibition Depends on the EMT Phenotype Associating with Clinical Outcome." Molecular Cancer 23, no. 1 (2024): 1. https://doi.org/10.1186/s12943-024-01954-8.

MLA (9th ed.) Citation

Broghammer, Felix, et al. "Resistance of HNSCC Cell Models to Pan-FGFR Inhibition Depends on the EMT Phenotype Associating with Clinical Outcome." Molecular Cancer, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12943-024-01954-8.